Sulforaphane for Reduced Oxidative Stress

Sulforaphane is the clearest example of an antioxidant that works by not being an antioxidant - it is a mild stressor that provokes the cell to defend itself.

Rather than neutralising radicals one for one like vitamin C, sulforaphane activates Nrf2 and upregulates hundreds of cytoprotective genes, producing a catalytic and long-lasting increase in endogenous antioxidant capacity. Human trials of broccoli sprout preparations show increased glutathione and detoxification enzyme activity, greater urinary excretion of pollutant conjugates, and reductions in markers such as malondialdehyde and C-reactive protein in some populations. The effect is most visible where oxidative burden is high - air pollution exposure, metabolic disease, smoking. In healthy, well-fed people with low baseline stress, the measurable change is smaller and the clinical meaning unclear.

Sulforaphane modifies reactive cysteine residues on Keap1, freeing Nrf2 from degradation so it can enter the nucleus and bind antioxidant response elements. This is hormesis: a mild electrophilic stress triggering a disproportionate protective response.

The resulting gene programme includes glutamate-cysteine ligase, which raises glutathione synthesis, glutathione S-transferases, NAD(P)H quinone dehydrogenase 1, heme oxygenase-1, and thioredoxin and peroxiredoxin systems. Because these are enzymes, each molecule handles many oxidants repeatedly, and because the response is transcriptional it persists for days after a single dose. This is why direct-acting antioxidant supplements and Nrf2 activators are not interchangeable, and why high-dose vitamin antioxidants have repeatedly failed in trials while the hormetic approach retains plausibility.

Conversion from precursor to active compound is the limiting step.

There are currently no studies linked to this pairing in our library, so no study list is shown.

Randomised human trials of broccoli sprout preparations demonstrate Nrf2 target gene induction, increased glutathione and detoxification enzyme activity, and accelerated excretion of airborne pollutant conjugates, with the large trial in Jiangsu Province providing the most robust real-world demonstration. Epidemiology consistently links cruciferous vegetable intake with better health outcomes. Limitations are real. Trials are short, small and biomarker-driven; sulforaphane preparations vary enormously in bioavailability, complicating comparison; individual conversion depends on gut microbiota and genotype; and no trial has shown that lowering oxidative stress markers with sulforaphane changes any hard clinical outcome.

Broccoli sprout preparations are well tolerated. Bloating, gas and mild digestive discomfort are common early on, and the sulphurous taste is the most frequent reason people stop.

High glucosinolate intake can interfere with thyroid iodine uptake, relevant chiefly with existing thyroid disease or low iodine status. Long-term safety of concentrated extracts is unstudied, pregnancy data are limited, and there is theoretical concern that sustained Nrf2 activation could protect established tumour cells - a point to raise with an oncology team.

The main conflicts involve blunting the very signal sulforaphane depends on.

No studies are currently linked to this pairing, so no reference list is available. This section will populate as evidence is added to the library.